Advertisement

A cohort study of personal and family history of skin cancer in relation to future risk of non-cutaneous malignancies

  • James Small
  • Kristin WallaceEmail author
  • Elizabeth G. Hill
  • Bruce H. Thiers
  • Brian C. Leach
  • Anthony J. Alberg
Original Paper
  • 12 Downloads

Abstract

Purpose

Skin cancer has repeatedly been observed to be a marker of increased risk for developing an internal malignancy. The purpose of our study was to further investigate this association while also characterizing the potential role of family history of skin cancer in relation to risk for non-cutaneous malignancies.

Methods

Our study used data from 8,408 participants from the NHANES I epidemiological follow-up study. Cox-proportional hazards models were used to estimate the risk for developing an internal cancer associated with a personal history and family history of skin cancer during follow-up.

Results

A personal history of skin cancer was associated with significantly increased risk of developing an internal cancer in adjusted models [hazard ratio (HR) 1.33, 95% confidence interval (CI) 1.09–1.61] but a family history of skin cancer was not associated with increased risk (HR 0.80, 95% CI 0.58–1.11).

Conclusions

Consistent with prior reports, a personal history of skin cancer was associated with increase of developing internal malignancies, but this did not hold true for a family history of skin cancer. Further research is needed to understand why a personal history of skin cancer acts as a marker for increased risk for internal cancer.

Keywords

Skin neoplasms/epidemiology Neoplasms, second primary/epidemiology Family medical history Cohort studies Follow-up studies Humans 

Notes

Acknowledgments

Supported in part by the Biostatistics Shared Resource of the Hollings Cancer Center, Medical University of South Carolina (P30 CA138313).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Stern RS (2010) Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 146:279–282.  https://doi.org/10.1016/j.yder.2011.02.032 CrossRefGoogle Scholar
  2. 2.
    Rogers HW, Weinstock MA, Harris AR et al (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283–287.  https://doi.org/10.1001/archdermatol.2010.19 CrossRefGoogle Scholar
  3. 3.
    Howlander N, Noone A, Krapcho M et al (2017) SEER cancer statistics review, 1974–2014. National Cancer Institute, BethesdaGoogle Scholar
  4. 4.
    Chen AC, Halliday GM, Damian DL (2013) Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology 45:331–341.  https://doi.org/10.1097/PAT.0b013e32835f515c CrossRefGoogle Scholar
  5. 5.
    Karagas MR, Weinstock MA (2006) Keratinocyte carcinomas. In: Schottenfeld D, Fraumenia J (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 1230–1250CrossRefGoogle Scholar
  6. 6.
    Lewis KG, Weinstock MA (2007) Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 127:2323–2327.  https://doi.org/10.1038/sj.jid.5700897 CrossRefGoogle Scholar
  7. 7.
    Ong ELH, Goldacre R, Hoang U et al (2014) Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study. Cancer Epidemiol Biomarkers Prev 23:490–498.  https://doi.org/10.1158/1055-9965.EPI-13-0902 CrossRefGoogle Scholar
  8. 8.
    Jung GW, Dover DC, Salopek TG (2014) Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009. Br J Dermatol 170:136–143.  https://doi.org/10.1111/bjd.12694 CrossRefGoogle Scholar
  9. 9.
    Chen J, Ruczinski I, Jorgensen TJ et al (2008) Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 100:1215–1222.  https://doi.org/10.1093/jnci/djn260 CrossRefGoogle Scholar
  10. 10.
    Wheless L, Black J, Alberg AJ (2010) Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomark Prev 19:1686–1695CrossRefGoogle Scholar
  11. 11.
    Rees JR, Zens MS, Gui J et al (2014) Non melanoma skin cancer and subsequent cancer risk. PLoS ONE 9:e99674.  https://doi.org/10.1371/journal.pone.0099674 CrossRefGoogle Scholar
  12. 12.
    Caini S, Boniol M, Botteri E et al (2014) The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis. J Dermatol Sci 75:3–9.  https://doi.org/10.1016/j.jdermsci.2014.02.007 CrossRefGoogle Scholar
  13. 13.
    Ruczinski I, Jorgensen TJ, Shugart YY et al (2012) A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype. Carcinogenesis 33:1692–1698CrossRefGoogle Scholar
  14. 14.
    Brewster AM, Alberg AJ, Strickland PT et al (2004) XPD Polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomark Prev 13:1271–1275Google Scholar
  15. 15.
    Small J, Barton V, Peterson B, Alberg AJ (2016) Keratinocyte carcinoma as a marker of a high cancer-risk phenotype. Adv Cancer Res 130:257–291.  https://doi.org/10.1016/bs.acr.2016.01.003 CrossRefGoogle Scholar
  16. 16.
    Gottschall H, Schmoecker C, Hartmann D et al (2018) Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue. J Lipid Res.  https://doi.org/10.1194/jlr.M078725 Google Scholar
  17. 17.
    Qiao Y, Yang T, Gan Y et al (2018) Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. BMC Cancer 18:288.  https://doi.org/10.1186/s12885-018-4156-5 CrossRefGoogle Scholar
  18. 18.
    Rothman K, Poole C, Tomantis L et al (1996) Cancer epidemiology and prevention, 2nd edn. Oxford University Press, New YorkGoogle Scholar
  19. 19.
    Small J, Flanagan C, Armeson K et al (2016) Family history of cutaneous and non-cutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: a case-control study. J Am Acad Dermatol 75:1066–1068.e7CrossRefGoogle Scholar
  20. 20.
    Ming ME, Levy RM, Hoffstad OJ et al (2004) Validity of patient self-reported history of skin cancer: editor’s comment. Arch Dermatol 140:730–735.  https://doi.org/10.1001/archderm.140.6.730 CrossRefGoogle Scholar
  21. 21.
    Holm A-SS, Wulf HC (2015) Self-reported skin cancer is unreliable. Eur J Epidemiol 30:159–162.  https://doi.org/10.1007/s10654-015-9992-x CrossRefGoogle Scholar
  22. 22.
    Bergmann MM, Calle EE, Mervis CA et al (1998) Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 147:556–562CrossRefGoogle Scholar
  23. 23.
    Parikh-Patel A, Allen M, Wright WE (2003) Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol 157:539–545.  https://doi.org/10.1093/aje/kwg006 CrossRefGoogle Scholar
  24. 24.
    Lucas RM, Mcmichael AJ, Armstrong BK, Smith WT (2008) Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol 37:654–667.  https://doi.org/10.1093/ije/dyn017 CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • James Small
    • 1
  • Kristin Wallace
    • 1
    • 2
    Email author
  • Elizabeth G. Hill
    • 1
    • 2
  • Bruce H. Thiers
    • 3
  • Brian C. Leach
    • 4
  • Anthony J. Alberg
    • 5
  1. 1.Department of Public Health SciencesMedical University of South CarolinaCharlestonUSA
  2. 2.Hollings Cancer CenterMedical University of South CarolinaCharlestonUSA
  3. 3.Dermatology and Dermatologic SurgeryMedical University of South CarolinaCharlestonUSA
  4. 4.The Skin Surgery Center of CharlestonMount PleasantUSA
  5. 5.Department of Epidemiology and Biostatistics, Arnold School of Public HealthUniversity of South CarolinaColumbiaUSA

Personalised recommendations